David is a partner in Miller Thomson’s Intellectual Property Group practising intellectual property litigation with a focus on patent litigation in the pharmaceutical and biomedical device industries.
He regularly acts for pharmaceutical companies in proceedings under the Patented Medicines (Notice of Compliance) Regulations as well as in patent infringement and invalidity actions.
David has many years of experience in multi-jurisdictional litigation matters and has worked closely with counsel in other countries on worldwide patent disputes.
In addition to extensive experience as counsel in patent litigation, David has experience as an expert witness on Canadian patent law in a multi-jurisdictional arbitration proceeding.
As an active member of the IP legal community, David is a regular presenter and contributor to intellectual property conferences and seminars. David has spoken extensively on many issues related to patent litigation and pharmaceutical patents, and he has been the Chair of the Legal Practices and Standards Committee of the Intellectual Property Section of the Canadian Bar Association.
Prior to entering the field of law, David worked for several years in the specialty chemicals business, focusing on additives for the building products and paint industries.